Challenges and Prospects of Patient-Derived Xenografts for Cancer Research

por Jin, Jiankang, Yoshimura, Katsuhiro, Sewastjanow-Silva, Matheus, Song, Shumei, Ajani, Jaffer A.
Publicado 2023

Tumor Suppressor Gene-Based Nanotherapy: From Test Tube to the Clinic

por Shanker, Manish, Jin, Jiankang, Branch, Cynthia D., Miyamoto, Shinya, Grimm, Elizabeth A., Roth, Jack A., Ramesh, Rajagopal
Publicado 2011

Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity

por Panneerselvam, Janani, Shanker, Manish, Jin, Jiankang, Branch, Cynthia D., Muralidharan, Ranganayaki, Zhao, Yan D., Chada, Sunil, Munshi, Anupama, Ramesh, Rajagopal
Publicado 2015

IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis

por Panneerselvam, Janani, Jin, Jiankang, Shanker, Manish, Lauderdale, Jason, Bates, Jonathan, Wang, Qi, Zhao, Yan D., Archibald, Stephen J., Hubin, Timothy J., Ramesh, Rajagopal
Publicado 2015

An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue

por Jin, Jiankang, Xu, Yan, Huo, Longfei, Ma, Lang, Scott, Ailing W., Pizzi, Melissa Pool, Li, Yuan, Wang, Ying, Yao, Xiaodan, Song, Shumei, Ajani, Jaffer A.
Publicado 2020

ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer

por Chen, Qiongrong, Song, Shumei, Wei, Shaozhong, Liu, Bin, Honjo, Soichiro, Scott, Ailing, Jin, Jiankang, Ma, Lang, Zhu, Haitao, Skinner, Heath D., Johnson, Randy L., Ajani, Jaffer A.
Publicado 2015

Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma

por Song, Shumei, Li, Yuan, Xu, Yan, Ma, Lang, Pool Pizzi, Melissa, Jin, Jiankang, Scott, Ailing W, Huo, Longfei, Wang, Ying, Lee, Jeffrey H., Bhutani, Manoop S., Weston, Brian, Shanbhag, Namita D, Johnson, Randy L., Ajani, Jaffer A.
Publicado 2020

LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma

por Li, Yuan, Song, Shumei, Pizzi, Melissa Pool, Han, Guangchun, Scott, Ailing W., Jin, Jiankang, Xu, Yan, Wang, Ying, Huo, Longfei, Ma, Lang, Vellano, Christopher, Luo, Xiaolin, MacLeod, Robert, Wang, Linghua, Wang, Zhenning, Ajani, Jaffer A.
Publicado 2020

A new intronic quantitative PCR method led to the discovery of transformation from human ascites to murine malignancy in a mouse model

por Jin, Jiankang, Huo, Longfei, Fan, Yibo, Wang, Ruiping, Scott, Ailing W., Pizzi, Melissa Pool, Yao, Xiaodan, Shao, Shan, Ma, Lang, Da Silva, Matheus S., Yamashita, Kohei, Yoshimura, Katsuhiro, Zhang, Boyu, Wu, Jingjing, Wang, Linghua, Song, Shumei, Ajani, Jaffer A.
Publicado 2023

LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma

por Xu, Yan, Li, Yuan, Jin, Jiankang, Han, Guangchun, Sun, Chengcao, Pizzi, Melissa Pool, Huo, Longfei, Scott, Ailing, Wang, Ying, Ma, Lang, Lee, Jeffrey H., Bhutani, Manoop S., Weston, Brian, Vellano, Christopher, Yang, Liuqing, Lin, Chunru, Kim, Youngsoo, MacLeod, A. Robert, Wang, Linghua, Wang, Zhenning, Song, Shumei, Ajani, Jaffer A.
Publicado 2019

Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma

por Xu, Yan, Li, Yuan, Jin, Jiankang, Han, Guangchun, Sun, Chengcao, Pizzi, Melissa Pool, Huo, Longfei, Scott, Ailing, Wang, Ying, Ma, Lang, Lee, Jeffrey H., Bhutani, Manoop S., Weston, Brian, Vellano, Christopher, Yang, Liuqing, Lin, Chunru, Kim, Youngsoo, MacLeod, A. Robert, Wang, Linghua, Wang, Zhenning, Song, Shumei, Ajani, Jaffer A.
Publicado 2021

Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma

por Song, Shumei, Xu, Yan, Huo, Longfei, Zhao, Shuangtao, Wang, Ruiping, Li, Yuan, Scott, Ailing W., Pizzi, Melissa Pool, Wang, Ying, Fan, Yibo, Harada, Kazuto, Jin, Jiankang, Ma, Lang, Yao, Xiaodan, Shanbhag, Namita D., Gan, Qiong, Roy-Chowdhuri, Sinchita, Badgwell, Brian D., Wang, Zhenning, Wang, Linghua, Ajani, Jaffer A.
Publicado 2021

Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors

por Ajani, Jaffer A, Estrella, Jeannelyn S, Chen, Qiongrong, Correa, Arlene M, Ma, Lang, Scott, Ailing W, Jin, Jiankang, Liu, Bin, Xie, Min, Sudo, Kazuki, Shiozaki, Hironori, Badgwell, Brian, Weston, Brian, Lee, Jeffrey H, Bhutani, Manoop S, Onodera, Hisashi, Suzuki, Koyu, Suzuki, Akihiro, Ding, Sheng, Hofstetter, Wayne L, Johnson, Randy L, Bresalier, Robert S, Song, Shumei
Publicado 2018

GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma

por Li, Yuan, Fan, Yibo, Xu, Jinbang, Huo, Longfei, Scott, Ailing W., Jin, Jiankang, Yang, Boxuan, Shao, Shan, Ma, Lang, Wang, Ying, Yao, Xiaodan, Pool Pizzi, Melissa, Sewastjanow Da Silva, Matheus, Zhang, Guoliang, Zhuo, Lijuan, Cho, Eun Jeong, Dalby, Kevin N., Shanbhag, Namita D., Wang, Zhenning, Li, Wenliang, Song, Shumei, Ajani, Jaffer A.
Publicado 2022